INTANGIBLE ASSETS (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jul. 31, 2017
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Fair value of assets acquired					$ 620,000
loss on impairment of an intangible asset			$ 338,000
Loss on impairment		$ 0	300,000
Amortization expense		$ 0	70,000
Symplmed Pharmaceuticals LLC [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
loss on impairment of an intangible asset			$ 322,000
Symplmed Technologies, LLC [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Intangible assets, current						$ 75,000
Purchase Agreement [Member] | Symplmed Pharmaceuticals LLC [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront payment of future consideration	$ 620,000
Payments to acquire businesses	300,000
Liabilities assumed	$ 320,000
Fair value of assets acquired				$ 161,000
Intangible assets, current				$ 459,000